The Potential Prognostic Impact and Intercorrelations between CTLA-4, PD-1/PD-L1 and CD73/A2AR Immune Checkpoint Molecules in Colorectal Cancer

被引：0
|
作者：
Aboelnasr, L. [1 ,2 ]
Abdou, A. [3 ]
机构：
[1] Menoufia Univ Hosp, Menoufia, Egypt
[2] Imperial Coll London, London, England
[3] Menoufia Univ, Menoufia, Egypt
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST150
引用
收藏
页码：S140 / S141
页数：2
相关论文
共 50 条
  • [31] Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
    Zhang, Hao
    Dai, Ziyu
    Wu, Wantao
    Wang, Zeyu
    Zhang, Nan
    Zhang, Liyang
    Zeng, Wen-Jing
    Liu, Zhixiong
    Cheng, Quan
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [32] Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
    Hao Zhang
    Ziyu Dai
    Wantao Wu
    Zeyu Wang
    Nan Zhang
    Liyang Zhang
    Wen-Jing Zeng
    Zhixiong Liu
    Quan Cheng
    Journal of Experimental & Clinical Cancer Research, 40
  • [33] PD-L1, PD-1, and CTLA-4 as prognostic biomarkers in resected non-small cell lung cancer.
    Owonikoko, Taofeek Kunle
    Kowalski, Jeanne
    Kim, Sungjin
    Dwivedi, Bhakti
    Chen, Zhengjia
    Behera, Madhusmita
    Mayfield, William
    Hermann, Robert C.
    Chen, Lieping
    Khuri, Fadlo Raja
    Ramalingam, Suresh S.
    Sica, Gabriel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis
    Aghbash, Parisa Shiri
    Eslami, Narges
    Shamekh, Ali
    Entezari-Maleki, Taher
    Baghi, Hossein Bannazadeh
    LIFE SCIENCES, 2021, 270
  • [35] Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
    Qin, Shuang
    Xu, Linping
    Yi, Ming
    Yu, Shengnan
    Wu, Kongming
    Luo, Suxia
    MOLECULAR CANCER, 2019, 18 (01)
  • [36] Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry
    Saygin, Ismail
    Cakir, Emel
    Kazaz, Seher Nazli
    Guvercin, Ali Riza
    Eyupoglu, Ilker
    Ustaoglu, Muserref Muge
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2024, 54 (04)
  • [37] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2019, 32
  • [38] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Iosune Baraibar
    Ignacio Melero
    Mariano Ponz-Sarvise
    Eduardo Castanon
    Drug Safety, 2019, 42 : 281 - 294
  • [39] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2019, 99
  • [40] Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
    Shuang Qin
    Linping Xu
    Ming Yi
    Shengnan Yu
    Kongming Wu
    Suxia Luo
    Molecular Cancer, 18
12345